MEDICINES CO's ticker is MDCO and the CUSIP is 584688105. A total of 198 filers reported holding MEDICINES CO in Q2 2018. The put-call ratio across all filers is 0.44 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $1,062,000 | -89.7% | 12,500 | -93.9% | 0.20% | -90.5% |
Q3 2019 | $10,304,000 | +203.5% | 206,100 | +121.4% | 2.17% | +225.2% |
Q2 2019 | $3,395,000 | +698.8% | 93,100 | +512.5% | 0.67% | +675.6% |
Q1 2019 | $425,000 | +0.5% | 15,200 | -31.2% | 0.09% | -31.2% |
Q4 2018 | $423,000 | -93.0% | 22,100 | -89.1% | 0.12% | -88.5% |
Q3 2018 | $6,056,000 | -11.2% | 202,500 | +9.0% | 1.09% | -17.2% |
Q2 2018 | $6,819,000 | +1193.9% | 185,813 | +1061.3% | 1.31% | +624.3% |
Q1 2018 | $527,000 | -93.2% | 16,000 | -92.3% | 0.18% | -91.8% |
Q3 2017 | $7,704,000 | -48.1% | 208,000 | -46.7% | 2.21% | -57.4% |
Q2 2017 | $14,835,000 | +299.2% | 390,300 | +413.6% | 5.20% | +185.7% |
Q1 2017 | $3,716,000 | +148.7% | 76,000 | +72.7% | 1.82% | +104.4% |
Q4 2016 | $1,494,000 | -39.1% | 44,000 | -32.3% | 0.89% | -11.2% |
Q3 2016 | $2,453,000 | – | 65,000 | – | 1.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 4,202,000 | $153,246,000 | 19.10% |
Antipodean Advisors LLC | 257,000 | $9,373,000 | 11.40% |
Aviva Holdings Ltd. | 982,831 | $35,844,000 | 7.50% |
BRIDGER MANAGEMENT, LLC | 2,314,014 | $84,392,000 | 6.62% |
Slate Path Capital LP | 3,545,000 | $129,286,000 | 5.80% |
CVI Holdings, LLC | 338,850 | $12,357,000 | 4.78% |
DLD Asset Management, LP | 2,917,800 | $106,412,000 | 4.43% |
Camber Capital Management LP | 1,700,000 | $61,999,000 | 2.89% |
Maven Securities LTD | 109,386 | $3,994,000 | 2.66% |
Parian Global Management LP | 110,100 | $4,015,000 | 2.60% |